Cargando…
Immunotherapeutic strategies targeting B cell maturation antigen in multiple myeloma
Multiple myeloma (MM) is the second most common hematologic malignancy, and is characterized by the clonal expansion of malignant plasma cells. Despite the recent improvement in patient outcome due to the use of novel therapeutic agents and stem cell transplantation, all patients eventually relapse...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839214/ https://www.ncbi.nlm.nih.gov/pubmed/33504363 http://dx.doi.org/10.1186/s40779-021-00302-x |